G

Glenmark Pharmaceuticals Ltd
NSE:GLENMARK

Watchlist Manager
Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Watchlist
Price: 1 550.6 INR 0.36% Market Closed
Market Cap: 437.6B INR
Have any thoughts about
Glenmark Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

GLENMARK Price Targets Summary
Glenmark Pharmaceuticals Ltd

Wall Street analysts forecast GLENMARK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLENMARK is 1 645.95 INR with a low forecast of 575.7 INR and a high forecast of 2 137.8 INR.

Lowest
Price Target
575.7 INR
63% Downside
Average
Price Target
1 645.95 INR
6% Upside
Highest
Price Target
2 137.8 INR
38% Upside
Glenmark Pharmaceuticals Ltd Competitors:
Price Targets
4530
Hisamitsu Pharmaceutical Co Inc
12% Upside
SAN
Sanofi SA
25% Upside
AQST
Aquestive Therapeutics Inc
208% Upside
4523
Eisai Co Ltd
56% Upside
603998
Hunan Fangsheng Pharmaceutical Co Ltd
42% Upside
FAE
Faes Farma SA
18% Upside
4577
Daito Pharmaceutical Co Ltd
40% Upside

Revenue
Forecast

Revenue Estimate
Glenmark Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's revenue is 6%. The projected CAGR for the next 3 years is 14%.

6%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Glenmark Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's operating income is -8%. The projected CAGR for the next 3 years is 71%.

-8%
Past Growth
71%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Glenmark Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GLENMARK's stock price target?
Price Target
1 645.95 INR

According to Wall Street analysts, the average 1-year price target for GLENMARK is 1 645.95 INR with a low forecast of 575.7 INR and a high forecast of 2 137.8 INR.

What is Glenmark Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's revenue is 6%. The projected CAGR for the next 3 years is 14%.

What is Glenmark Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
71%

For the last 8 years the compound annual growth rate for Glenmark Pharmaceuticals Ltd's operating income is -8%. The projected CAGR for the next 3 years is 71%.

Back to Top